| Literature DB >> 33633281 |
Marcus Pehar1, Andrew J Thompson1, Urva Azeem1, Kiana Jahanbakhsh1, Fahad Iqbal1, Nerea Jimenez-Tellez1, Rasha Sabouny1, Shadab Batool1, Atika Syeda2, Jennifer Chow1, Pranav Machiraju1, Timothy Shutt1, Kamran Yusuf1, Jane Shearer1, Tiffany Rice1, Naweed I Syed3.
Abstract
Anesthetics are deemed necessary for all major surgical procedures. However, they have also been found to exert neurotoxic effects when tested on various experimental models, but the underlying mechanisms remain unknown. Earlier studies have implicated mitochondrial fragmentation as a potential target of anesthetic-induced toxicity, although clinical strategies to protect their structure and function remain sparse. Here, we sought to determine if preserving mitochondrial networks with a non-toxic, short-life synthetic peptide-P110, would protect cortical neurons against both inhalational and intravenous anesthetic-induced neurotoxicity. This study provides the first direct and comparative account of three key anesthetics (desflurane, propofol, and ketamine) when used under identical conditions, and demonstrates their impact on neonatal, rat cortical neuronal viability, neurite outgrowth and synaptic assembly. Furthermore, we discovered that inhibiting Fis1-mediated mitochondrial fission reverses anesthetic-induced aberrations in an agent-specific manner. This study underscores the importance of designing mitigation strategies invoking mitochondria-mediated protection from anesthetic-induced toxicity in both animals and humans.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33633281 PMCID: PMC7907385 DOI: 10.1038/s41598-021-84168-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379